Real-life long-term outcomes for patients treated with the 0.19 mg fluocinolone acetonide (FAc; ILUVIEN) intravitreal implant for DME: Three-year follow-up from the RegIstry Safety Study (IRISS).

Iluvien (fluocinolone acetonide) - Alimera Sci, EyePoint Pharma

Ramin Khoramnia1; Frank H J Koch1; Usha Chakravarthy2; Simon R. Taylor3; Joao Paulo Castro de Sousa4; Clare Bailey5

Mar 9, 2020